| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K26531177 |
| PharmacoGx | BRD-K26531177 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RP11-2C24.9 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ZNF764 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ZNF629 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CYS1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ZNF425 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | EMC4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | HAPLN1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ASAH1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | HSF5 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CLRN2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
